Allstate Corporation’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.28M Sell
11,593
-1,678
-13% -$162K 0.01% 525
2026
Q2
$1.04M Buy
13,271
+2,065
+18% +$141K 0.01% 736
2026
Q1
$724K Buy
+11,206
New +$790K 0.01% 912

Other funds holding HALO

Allstate Corporation's HALO Position: Q3 2026 in Review

Allstate Corporation reduced its Halozyme (HALO) stake by 13% in Q3 2026, selling an estimated $162K and leaving 11,593 shares worth $1.28M. The position accounts for 0.01% of the portfolio, ranked #525.

Allstate Corporation first reported a position in HALO in Q1 2026 and has held it in 3 quarters since. 714 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Allstate Corporation held 11,593 shares of Halozyme worth $1.28M as of Q3 2026.
  • Allstate Corporation sold 1,678 Halozyme shares in Q3 2026, an estimated $162K.
  • Halozyme made up 0.01% of Allstate Corporation's portfolio in Q3 2026, its #525 holding.
  • Allstate Corporation first reported a position in Halozyme in Q1 2026 and has held it in 3 quarters since.
  • 714 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Allstate Corporation's 13F filing for Q3 2026, filed 16 Nov 2026.